Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-12,200
Closed -$371K 740
2022
Q2
$371K Hold
12,200
﹤0.01% 626
2022
Q1
$429K Buy
+12,200
New +$434K ﹤0.01% 625
2021
Q3
Sell
-15,300
Closed -$402K 794
2021
Q2
$402K Hold
15,300
﹤0.01% 650
2021
Q1
$400K Buy
+15,300
New +$428K ﹤0.01% 686
2019
Q1
Sell
-20,900
Closed -$447K 856
2018
Q4
$447K Hold
20,900
0.01% 664
2018
Q3
$537K Hold
20,900
0.01% 665
2018
Q2
$489K Buy
20,900
+12,800
+158% +$331K 0.01% 672
2018
Q1
$230K Buy
+8,100
New +$237K 0.01% 568

Other funds holding PHI

Segall Bryant & Hamill's PHI Position: Q3 2022 in Review

Segall Bryant & Hamill sold out of PLDT (PHI) in Q3 2022, closing a stake of 12,200 shares — an estimated $371K sold.

Segall Bryant & Hamill first reported a position in PHI in Q1 2018 and held it in 8 quarters. The position peaked at $537K in Q3 2018. 70 funds tracked by Wall St. Rank hold PHI as of Q3 2022.

  • Segall Bryant & Hamill reported no remaining PLDT position as of Q3 2022 after selling out during the quarter.
  • Segall Bryant & Hamill sold 12,200 PLDT shares in Q3 2022, an estimated $371K.
  • Segall Bryant & Hamill first reported a position in PLDT in Q1 2018 and held it in 8 quarters.
  • Segall Bryant & Hamill's PLDT position peaked at $537K in Q3 2018.
  • 70 funds tracked by Wall St. Rank held PLDT as of Q3 2022.

Based on Segall Bryant & Hamill's 13F filing for Q3 2022, filed 14 Nov 2022.